— Know what they know.
Not Investment Advice
Also trades as: KOPRAN.NS (NSE) · $vol 3M

KOPRAN.BO BSE

Kopran Limited
1W: +4.1% 1M: +30.6% 3M: +44.9% YTD: +97.6% 1Y: +82.0% 3Y: +61.2% 5Y: +22.6%
₹283.90 ($2.95)
+5.80 (+2.09%)
 
BSE · Healthcare · Drug Manufacturers - General · Tech Score Buy · Power 63 · ₹13.7B mcap · 23M float · 0.283% daily turnover
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₹13.7B ($142.5M)
52W Range107-295.9
Volume33,711
Avg Volume63,933
Beta0.86
Dividend₹3.00
Analyst Ratings
No analyst coverage
Company Info
CEOSurendra Shrikrishna Somani
Employees1,156
SectorHealthcare
IndustryDrug Manufacturers - General
IPO Date2000-01-03
Websitekopran.com
Parijat House
Mumbai, MA 400018
IN
91 22 4366 1111
About Kopran Limited

Kopran Limited is an integrated pharmaceutical enterprise specializing in the production and global distribution of both active pharmaceutical ingredients (APIs) and finished dosage forms. The company offers a comprehensive range of drug presentations, such as tablets, capsules, liquid syrups, dry powders, suspensions, injectable solutions, and topical applications. Its diverse therapeutic focus includes antimicrobials (macrolide, antibacterial, anti-infective, antiprotozoal, anthelmintics), neurological treatments (anticonvulsant, central nervous system), cardiovascular medications (anti-hypertensive, anti-thrombotic), metabolic disorder management (antidiabetic), pain relief, gastroenterology (antipeptic ulcer), urological solutions (erectile dysfunction), antiallergics, respiratory care, oncology, and dermatological products (anti-acne). Founded in 1958, Kopran Limited is based in Mumbai, India.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms